Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Another noteworthy association was the vitamin D receptor gene (most significant P = .007).
Source: Query of Previously Studied TB Candidate Genes and Host-pathogen Interaction Effects. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Review / evidence synthesis.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
We considered meta-analysis results attaining P < 10−5 as “suggestive”.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Human Genetic Variation Associates With Infection by Derived Ugandan M. tuberculosis Lineage
Review / evidence synthesis · The Journal of Infectious Diseases · 2026
Original publication title
Human Genetic Variation Associates With Infection by Derived Ugandan M. tuberculosis Lineage
© The Author(s) 2026. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Several studies have examined host and pathogen genetic influences on tuberculosis (TB) susceptibility separately, but relatively few studied their combined effects. However, host-pathogen interactions or co-evolution may explain the inability to replicate many reported human genetic effects across global populations and provide additional insight into TB risk. In this study, we address such possible interactions by focusing on the outcome of infection with the L4-Uganda M. tuberculosis sub-lineage and human genetic variants as independent variables. This is possible because the L4-Uganda sub-lineage is both restricted to Uganda and nearby locations and is recent there, compared with other more ancestral L4 lineages.
Source: BackgroundAbstract: What methods does the paper describe?
Our study consisted of 276 culture-confirmed adult TB cases from a long-standing household contact study. We conducted a genome-wide association study, with infection with L4-Uganda versus L4-NonUganda as the outcome.
Source: MethodsAbstract: Results
Multiple loci with results suggestive of association (P < 10−5) also demonstrated convergent relevant evidence for strain specific infection via: evidence of gene expression in relevant cells and lung tissue, signatures of natural selection, eQTL expression, and CRISPR screens for immunity-related genes. We also replicated previously published host-pathogen interaction effects, demonstrating that effects seen for other sub-lineages were also present for L4-Uganda.
Source: ResultsAbstract: Conclusions
These results provide evidence for host-pathogen co-evolution in TB, consistent with our previous work, and indicate these interactions involve genes highly relevant to the host immune response to Mycobacterium infection.
Source: ConclusionsAuthors’ abstract
Abstract
Background
Several studies have examined host and pathogen genetic influences on tuberculosis (TB) susceptibility separately, but relatively few studied their combined effects. However, host-pathogen interactions or co-evolution may explain the inability to replicate many reported human genetic effects across global populations and provide additional insight into TB risk. In this study, we address such possible interactions by focusing on the outcome of infection with the L4-Uganda M. tuberculosis sub-lineage and human genetic variants as independent variables. This is possible because the L4-Uganda sub-lineage is both restricted to Uganda and nearby locations and is recent there, compared with other more ancestral L4 lineages.
Methods
Our study consisted of 276 culture-confirmed adult TB cases from a long-standing household contact study. We conducted a genome-wide association study, with infection with L4-Uganda versus L4-NonUganda as the outcome.
Results
Multiple loci with results suggestive of association (P < 10−5) also demonstrated convergent relevant evidence for strain specific infection via: evidence of gene expression in relevant cells and lung tissue, signatures of natural selection, eQTL expression, and CRISPR screens for immunity-related genes. We also replicated previously published host-pathogen interaction effects, demonstrating that effects seen for other sub-lineages were also present for L4-Uganda.
Conclusions
These results provide evidence for host-pathogen co-evolution in TB, consistent with our previous work, and indicate these interactions involve genes highly relevant to the host immune response to Mycobacterium infection.
This study examined host genetic determinants of infection with the L4-Uganda tuberculosis lineage using a genome-wide association study. Supportive analyses for most significant effects included bioinformatics and eQTL data. Findings implicate immune response genes in host-pathogen interactions in TB.
Publication and source details
Original title: Human Genetic Variation Associates With Infection by Derived Ugandan M. tuberculosis Lineage
Catherine M Stein; Penelope Benchek; Lentlamatse Mantshoyane; Timothy Ciesielski; Michael L McHenry; Himiede Wilson-Sesay; Moses Joloba; Eddie Wampande; Kimberly A Dill Mc-Farland; Allison W Roberts; Ben Polacco; Max Bennett; Nevan Krogan; W Henry Boom; Jeffery S Cox; Harriet Mayanja-Kizza; Thomas R Hawn; Scott M Williams
The Journal of Infectious Diseases · 2026
Correspondence: Catherine Stein, PhD, Department of Population and Quantitative Health Sciences, Case Western Reserve University, 2103 Cornell Rd Room 1316, Cleveland OH 44106 (cmj7@case.edu).Potential conflicts of interest. The Krogan Laboratory has received research support from Vir Biotechnology, F. Hoffmann-La Roche, and Rezo Therapeutics. N. K. has a financially compensated consulting agreement with Maze Therapeutics. N. K. is the CEO and is on the Board of Directors of Mreza Therapeutics, and he is a shareholder in Mreza Therapeutics, Rezo Therapeutics, Tenaya Therapeutics, Maze Therapeutics, and GEn1E Lifesciences. The other authors have no conflicts of interest to report. The authors: No reported conflicts of interest.
All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:46:48.800964+00:00
DOI: 10.1093/infdis/jiag218 · PMC13600372